Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Not Yet Recruiting

Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

NCT07696481

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
Locations: Department of Hematology, Zhujiang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

NCT07695896

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma

NCT07686744

Conditions: Adenocarcinoma, Advanced, Carcinoma, +21 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT07686588

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and Neck

NCT07682675

Conditions: Adenoid Cystic Carcinoma of the Salivary Gland, Disease Attributes, Metastatic Disease, +6 more
Locations: Oncopole Claudius Regaud Toulouse, France

Gustave Roussy Villejuif, France

View Trial Details

Not Yet Recruiting

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

NCT07681596

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Research Site Duarte, California, United States

Research Site Denver, Colorado, United States

Research Site Tampa, Florida, United States

Research Site Atlanta, Georgia, United States

View Trial Details

Not Yet Recruiting

Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva

NCT07672782

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +22 more
Locations: Atrium Health Levine Cancer Center Charlotte, North Carolina, United States

View Trial Details

Not Yet Recruiting

GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma

NCT07670260

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT07669194

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

NCT07659678

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recurrence

Recurrence trial results

Related conditions